시장보고서
상품코드
1873660

세계의 사전 멸균 시린지 시장 : 시장 점유율과 순위, 전체 판매 및 수요 예측(2025-2031년)

Pre-Sterilized Syringe - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

발행일: | 리서치사: QYResearch | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

세계의 사전 멸균 시린지 시장 규모는 2024년에 45억 4,800만 달러로 추정되며, 2025년부터 2031년까지 예측 기간 동안 CAGR 5.8%로 확대되어 2031년까지 64억 9,200만 달러에 달할 것으로 예측됩니다.

이 보고서는 사전 멸균 시린지의 국경 간 산업 발자국, 자본 배분 패턴, 지역 경제의 상호 의존성, 공급망 재구축에 대한 최근 관세 조정 및 국제적인 전략적 대응책에 대한 종합적인 평가를 제공합니다.

사전 멸균 시린지(프리 필드 시린지라고도 함)는 '약품 보존'과 '주사 기능'을 통합한 제품입니다. 실용적인 새로운 주사 형태로서 주로 백신 및 비멸균 생물학적 제제에 사용됩니다.

사전 멸균 시린지 산업의 집중도가 높지 않고, 전 세계에 100개 이상의 제조업체가 존재하며, 고급 제품은 주로 미국과 서유럽에서 공급됩니다.

세계 주요 제조업체는 주로 미국과 EU에 분포되어 있습니다. 미국 제조업체는 이 분야에서 오랜 역사와 확고한 지위를 가지고 있으며, BD와 같은 제조업체는 제품의 품질 수준이 상대적으로 높습니다. 독일에서는 Gerresheimer가 기술 개발을 주도하고 있으며, 세계 2위의 규모로 유럽에서는 선두를 차지하고 있습니다. 중국 제조업체의 대부분은 산동성에 위치하고 있습니다.

많은 기업들은 여러 개의 공장을 보유하고 있으며, 일반적으로 대상 소비 지역과 가까운 곳에 위치하고 있습니다.

주요 소비시장은 선진국에 집중되어 있습니다. 북미가 43.4%의 시장 점유율을 차지하고 있으며, 유럽이 28.0%로 그 뒤를 잇고 있습니다. 아시아태평양의 소비 시장은 지난 몇 년 동안 급속한 성장세를 보이고 있습니다.

이 보고서는 세계 사전 멸균 시린지 시장에 대해 총 판매량, 매출액, 가격, 주요 기업의 시장 점유율 및 순위에 초점을 맞추고 지역/국가, 유형 및 용도별 분석을 종합적으로 제공하는 것을 목표로 합니다.

이 보고서는 2024년을 기준 연도, 2020년에서 2031년까지의 과거 데이터와 예측 데이터를 포함하여 판매량(천 단위) 및 매출액(백만 달러)으로 사전 멸균 시린지 시장 규모, 추정 및 예측을 제시합니다. 정량적, 정성적 분석을 통해 독자들이 비즈니스/성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 포지셔닝 분석, 사전 멸균 시린지 관련 정보에 입각한 비즈니스 의사결정을 내릴 수 있도록 도와드립니다.

시장 세분화

기업별

  • BD
  • Gerresheimer
  • Nipro Corporation
  • Schott
  • Stevanato
  • Simtra(Baxter)
  • Rovi CM
  • Terumo
  • Vetter
  • Catalent
  • Taisei Kako
  • J.O.Pharma
  • West Pharma
  • Weigao Group
  • Shandong Zibo Minkang
  • Shandong Pharmaceutical Glass
  • Ningbo Zhengli
  • Shandong Ujoin

유형별 부문

  • 유리 유형
  • 플라스틱 유형

용도별 부문

  • 백신
  • 항혈전제
  • 바이오엔지니어링 의약품
  • 기타(미용 등)

지역별

  • 북미
    • 미국
    • 캐나다
  • 아시아태평양
    • 중국
    • 일본
    • 한국
    • 동남아시아
    • 인도
    • 호주
    • 기타 아시아태평양
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 네덜란드
    • 북유럽 국가
    • 기타 유럽
  • 라틴아메리카
    • 멕시코
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 튀르키예
    • 사우디아라비아
    • 아랍에미리트
    • 기타 중동 및 아프리카
KSM 25.12.24

자주 묻는 질문

  • 세계 사전 멸균 시린지 시장 규모는 어떻게 예측되나요?
  • 사전 멸균 시린지의 주요 소비 시장은 어디인가요?
  • 사전 멸균 시린지 산업의 주요 제조업체는 어디에 위치하고 있나요?
  • 사전 멸균 시린지의 용도는 무엇인가요?
  • 사전 멸균 시린지의 유형은 어떤 것이 있나요?
  • 사전 멸균 시린지 시장의 주요 기업은 어떤 곳이 있나요?

The global market for Pre-Sterilized Syringe was estimated to be worth US$ 4548 million in 2024 and is forecast to a readjusted size of US$ 6492 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Pre-Sterilized Syringe cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Pre-Sterilized Syringe, also called as Pre-filled Syringe, which integrates "storage medicine" and "injection function" into one. Practical and new injection forms are mainly used in vaccines and non-terminally sterilized biological agents.

The Pre-Sterilized Syringe industry concentration is not high; there are more than one hundreds manufacturers in the world, and high-end products mainly from U.S. and Western European.

Global giant manufactures mainly distributed in U.S. and E.U. The manufacturers in U.S. have a long history and unshakable status in this field. Manufacturers such as BD have relative higher level of product's quality. In Germany, Gerresheimer leads the technology development, it is the world's second largest player and the No.1 players in Europe. Most of Chinese manufactures locate in Shandong province.

Many companies have several plants, usually locate in the place close to aimed consumption region.

The key consumption markets locate at developed countries. The North America takes the market share of 43.4%, followed by Europe with 28.0%. Asia-Pacific's consumption market has a quicker growing speed of in the past few years.

This report aims to provide a comprehensive presentation of the global market for Pre-Sterilized Syringe, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Pre-Sterilized Syringe by region & country, by Type, and by Application.

The Pre-Sterilized Syringe market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pre-Sterilized Syringe.

Market Segmentation

By Company

  • BD
  • Gerresheimer
  • Nipro Corporation
  • Schott
  • Stevanato
  • Simtra (Baxter)
  • Rovi CM
  • Terumo
  • Vetter
  • Catalent
  • Taisei Kako
  • J.O.Pharma
  • West Pharma
  • Weigao Group
  • Shandong Zibo Minkang
  • Shandong Pharmaceutical Glass
  • Ningbo Zhengli
  • Shandong Ujoin

Segment by Type

  • Glass Type
  • Plastic Type

Segment by Application

  • Vaccine
  • Antithrombotic Drugs
  • Bioengineered Drugs
  • Other (Beauty, etc.)

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Pre-Sterilized Syringe manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Pre-Sterilized Syringe in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Pre-Sterilized Syringe in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Pre-Sterilized Syringe Product Introduction
  • 1.2 Global Pre-Sterilized Syringe Market Size Forecast
    • 1.2.1 Global Pre-Sterilized Syringe Sales Value (2020-2031)
    • 1.2.2 Global Pre-Sterilized Syringe Sales Volume (2020-2031)
    • 1.2.3 Global Pre-Sterilized Syringe Sales Price (2020-2031)
  • 1.3 Pre-Sterilized Syringe Market Trends & Drivers
    • 1.3.1 Pre-Sterilized Syringe Industry Trends
    • 1.3.2 Pre-Sterilized Syringe Market Drivers & Opportunity
    • 1.3.3 Pre-Sterilized Syringe Market Challenges
    • 1.3.4 Pre-Sterilized Syringe Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Pre-Sterilized Syringe Players Revenue Ranking (2024)
  • 2.2 Global Pre-Sterilized Syringe Revenue by Company (2020-2025)
  • 2.3 Global Pre-Sterilized Syringe Players Sales Volume Ranking (2024)
  • 2.4 Global Pre-Sterilized Syringe Sales Volume by Company Players (2020-2025)
  • 2.5 Global Pre-Sterilized Syringe Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Pre-Sterilized Syringe Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Pre-Sterilized Syringe Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Pre-Sterilized Syringe
  • 2.9 Pre-Sterilized Syringe Market Competitive Analysis
    • 2.9.1 Pre-Sterilized Syringe Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Pre-Sterilized Syringe Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pre-Sterilized Syringe as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Glass Type
    • 3.1.2 Plastic Type
  • 3.2 Global Pre-Sterilized Syringe Sales Value by Type
    • 3.2.1 Global Pre-Sterilized Syringe Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Pre-Sterilized Syringe Sales Value, by Type (2020-2031)
    • 3.2.3 Global Pre-Sterilized Syringe Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Pre-Sterilized Syringe Sales Volume by Type
    • 3.3.1 Global Pre-Sterilized Syringe Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Pre-Sterilized Syringe Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Pre-Sterilized Syringe Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Pre-Sterilized Syringe Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Vaccine
    • 4.1.2 Antithrombotic Drugs
    • 4.1.3 Bioengineered Drugs
    • 4.1.4 Other (Beauty, etc.)
  • 4.2 Global Pre-Sterilized Syringe Sales Value by Application
    • 4.2.1 Global Pre-Sterilized Syringe Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Pre-Sterilized Syringe Sales Value, by Application (2020-2031)
    • 4.2.3 Global Pre-Sterilized Syringe Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Pre-Sterilized Syringe Sales Volume by Application
    • 4.3.1 Global Pre-Sterilized Syringe Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Pre-Sterilized Syringe Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Pre-Sterilized Syringe Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Pre-Sterilized Syringe Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Pre-Sterilized Syringe Sales Value by Region
    • 5.1.1 Global Pre-Sterilized Syringe Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Pre-Sterilized Syringe Sales Value by Region (2020-2025)
    • 5.1.3 Global Pre-Sterilized Syringe Sales Value by Region (2026-2031)
    • 5.1.4 Global Pre-Sterilized Syringe Sales Value by Region (%), (2020-2031)
  • 5.2 Global Pre-Sterilized Syringe Sales Volume by Region
    • 5.2.1 Global Pre-Sterilized Syringe Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Pre-Sterilized Syringe Sales Volume by Region (2020-2025)
    • 5.2.3 Global Pre-Sterilized Syringe Sales Volume by Region (2026-2031)
    • 5.2.4 Global Pre-Sterilized Syringe Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Pre-Sterilized Syringe Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Pre-Sterilized Syringe Sales Value, 2020-2031
    • 5.4.2 North America Pre-Sterilized Syringe Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Pre-Sterilized Syringe Sales Value, 2020-2031
    • 5.5.2 Europe Pre-Sterilized Syringe Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Pre-Sterilized Syringe Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Pre-Sterilized Syringe Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Pre-Sterilized Syringe Sales Value, 2020-2031
    • 5.7.2 South America Pre-Sterilized Syringe Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Pre-Sterilized Syringe Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Pre-Sterilized Syringe Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Pre-Sterilized Syringe Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Pre-Sterilized Syringe Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Pre-Sterilized Syringe Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Pre-Sterilized Syringe Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Pre-Sterilized Syringe Sales Value, 2020-2031
    • 6.3.2 United States Pre-Sterilized Syringe Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Pre-Sterilized Syringe Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Pre-Sterilized Syringe Sales Value, 2020-2031
    • 6.4.2 Europe Pre-Sterilized Syringe Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Pre-Sterilized Syringe Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Pre-Sterilized Syringe Sales Value, 2020-2031
    • 6.5.2 China Pre-Sterilized Syringe Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Pre-Sterilized Syringe Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Pre-Sterilized Syringe Sales Value, 2020-2031
    • 6.6.2 Japan Pre-Sterilized Syringe Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Pre-Sterilized Syringe Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Pre-Sterilized Syringe Sales Value, 2020-2031
    • 6.7.2 South Korea Pre-Sterilized Syringe Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Pre-Sterilized Syringe Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Pre-Sterilized Syringe Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Pre-Sterilized Syringe Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Pre-Sterilized Syringe Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Pre-Sterilized Syringe Sales Value, 2020-2031
    • 6.9.2 India Pre-Sterilized Syringe Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Pre-Sterilized Syringe Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 BD
    • 7.1.1 BD Company Information
    • 7.1.2 BD Introduction and Business Overview
    • 7.1.3 BD Pre-Sterilized Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 BD Pre-Sterilized Syringe Product Offerings
    • 7.1.5 BD Recent Development
  • 7.2 Gerresheimer
    • 7.2.1 Gerresheimer Company Information
    • 7.2.2 Gerresheimer Introduction and Business Overview
    • 7.2.3 Gerresheimer Pre-Sterilized Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Gerresheimer Pre-Sterilized Syringe Product Offerings
    • 7.2.5 Gerresheimer Recent Development
  • 7.3 Nipro Corporation
    • 7.3.1 Nipro Corporation Company Information
    • 7.3.2 Nipro Corporation Introduction and Business Overview
    • 7.3.3 Nipro Corporation Pre-Sterilized Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Nipro Corporation Pre-Sterilized Syringe Product Offerings
    • 7.3.5 Nipro Corporation Recent Development
  • 7.4 Schott
    • 7.4.1 Schott Company Information
    • 7.4.2 Schott Introduction and Business Overview
    • 7.4.3 Schott Pre-Sterilized Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Schott Pre-Sterilized Syringe Product Offerings
    • 7.4.5 Schott Recent Development
  • 7.5 Stevanato
    • 7.5.1 Stevanato Company Information
    • 7.5.2 Stevanato Introduction and Business Overview
    • 7.5.3 Stevanato Pre-Sterilized Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Stevanato Pre-Sterilized Syringe Product Offerings
    • 7.5.5 Stevanato Recent Development
  • 7.6 Simtra (Baxter)
    • 7.6.1 Simtra (Baxter) Company Information
    • 7.6.2 Simtra (Baxter) Introduction and Business Overview
    • 7.6.3 Simtra (Baxter) Pre-Sterilized Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Simtra (Baxter) Pre-Sterilized Syringe Product Offerings
    • 7.6.5 Simtra (Baxter) Recent Development
  • 7.7 Rovi CM
    • 7.7.1 Rovi CM Company Information
    • 7.7.2 Rovi CM Introduction and Business Overview
    • 7.7.3 Rovi CM Pre-Sterilized Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Rovi CM Pre-Sterilized Syringe Product Offerings
    • 7.7.5 Rovi CM Recent Development
  • 7.8 Terumo
    • 7.8.1 Terumo Company Information
    • 7.8.2 Terumo Introduction and Business Overview
    • 7.8.3 Terumo Pre-Sterilized Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Terumo Pre-Sterilized Syringe Product Offerings
    • 7.8.5 Terumo Recent Development
  • 7.9 Vetter
    • 7.9.1 Vetter Company Information
    • 7.9.2 Vetter Introduction and Business Overview
    • 7.9.3 Vetter Pre-Sterilized Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Vetter Pre-Sterilized Syringe Product Offerings
    • 7.9.5 Vetter Recent Development
  • 7.10 Catalent
    • 7.10.1 Catalent Company Information
    • 7.10.2 Catalent Introduction and Business Overview
    • 7.10.3 Catalent Pre-Sterilized Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 Catalent Pre-Sterilized Syringe Product Offerings
    • 7.10.5 Catalent Recent Development
  • 7.11 Taisei Kako
    • 7.11.1 Taisei Kako Company Information
    • 7.11.2 Taisei Kako Introduction and Business Overview
    • 7.11.3 Taisei Kako Pre-Sterilized Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 Taisei Kako Pre-Sterilized Syringe Product Offerings
    • 7.11.5 Taisei Kako Recent Development
  • 7.12 J.O.Pharma
    • 7.12.1 J.O.Pharma Company Information
    • 7.12.2 J.O.Pharma Introduction and Business Overview
    • 7.12.3 J.O.Pharma Pre-Sterilized Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 J.O.Pharma Pre-Sterilized Syringe Product Offerings
    • 7.12.5 J.O.Pharma Recent Development
  • 7.13 West Pharma
    • 7.13.1 West Pharma Company Information
    • 7.13.2 West Pharma Introduction and Business Overview
    • 7.13.3 West Pharma Pre-Sterilized Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.13.4 West Pharma Pre-Sterilized Syringe Product Offerings
    • 7.13.5 West Pharma Recent Development
  • 7.14 Weigao Group
    • 7.14.1 Weigao Group Company Information
    • 7.14.2 Weigao Group Introduction and Business Overview
    • 7.14.3 Weigao Group Pre-Sterilized Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.14.4 Weigao Group Pre-Sterilized Syringe Product Offerings
    • 7.14.5 Weigao Group Recent Development
  • 7.15 Shandong Zibo Minkang
    • 7.15.1 Shandong Zibo Minkang Company Information
    • 7.15.2 Shandong Zibo Minkang Introduction and Business Overview
    • 7.15.3 Shandong Zibo Minkang Pre-Sterilized Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.15.4 Shandong Zibo Minkang Pre-Sterilized Syringe Product Offerings
    • 7.15.5 Shandong Zibo Minkang Recent Development
  • 7.16 Shandong Pharmaceutical Glass
    • 7.16.1 Shandong Pharmaceutical Glass Company Information
    • 7.16.2 Shandong Pharmaceutical Glass Introduction and Business Overview
    • 7.16.3 Shandong Pharmaceutical Glass Pre-Sterilized Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.16.4 Shandong Pharmaceutical Glass Pre-Sterilized Syringe Product Offerings
    • 7.16.5 Shandong Pharmaceutical Glass Recent Development
  • 7.17 Ningbo Zhengli
    • 7.17.1 Ningbo Zhengli Company Information
    • 7.17.2 Ningbo Zhengli Introduction and Business Overview
    • 7.17.3 Ningbo Zhengli Pre-Sterilized Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.17.4 Ningbo Zhengli Pre-Sterilized Syringe Product Offerings
    • 7.17.5 Ningbo Zhengli Recent Development
  • 7.18 Shandong Ujoin
    • 7.18.1 Shandong Ujoin Company Information
    • 7.18.2 Shandong Ujoin Introduction and Business Overview
    • 7.18.3 Shandong Ujoin Pre-Sterilized Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.18.4 Shandong Ujoin Pre-Sterilized Syringe Product Offerings
    • 7.18.5 Shandong Ujoin Recent Development

8 Industry Chain Analysis

  • 8.1 Pre-Sterilized Syringe Industrial Chain
  • 8.2 Pre-Sterilized Syringe Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Pre-Sterilized Syringe Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Pre-Sterilized Syringe Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제